{"id":1679,"date":"2017-01-20T08:16:52","date_gmt":"2017-01-20T13:16:52","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=1679"},"modified":"2017-01-20T08:17:34","modified_gmt":"2017-01-20T13:17:34","slug":"ipo-boutique-pipeline-new-filings-terms-in-last-seven-days","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-boutique-pipeline-new-filings-terms-in-last-seven-days\/","title":{"rendered":"IPO Boutique Pipeline: New Filings & Terms in Last Seven Days"},"content":{"rendered":"

SUBSCRIBE TO IPOBoutique\u2019s Free Weekly Newsletter<\/a><\/em><\/h3>\n
\n

 <\/p>\n

Link to entire IPO Boutique Pipeline<\/a><\/p>\n

NEW FILINGS<\/span><\/strong><\/h3>\n

Company: Foundation Building Materials<\/strong>
\nSymbol: FBM
\nPrice: TBD
\nDescription: They are the second largest specialty distributor of wallboard and suspended ceiling systems in the United States and Canada, and the fastest growing by revenue and branch count since our founding in 2011.
\nTrade Date: TBD
\nShares: TBD
\nUnderwriter(s): Deutsche Bank Securities, Barclays, RBC Capital Markets, Citigroup
\nCo Manager(s): Raymond James, Stephens Inc., SunTrust Robinson Humphrey, William Blair
\nFiled: 1\/13<\/p>\n

TERMS ADDED<\/strong><\/span><\/h3>\n

Company: ObsEva, Inc<\/strong>
\nSymbol: OBSV
\nPrice: $14.00-$16.00
\nDescription: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.
\nTrade Date: 1\/26
\nShares: 6.5 million
\nUnderwriter(s): Credit Suisse, Jefferies, Leerink Partners
\nCo Manager(s): N\/A<\/p>\n

Company: AnaptysBio, Inc.<\/strong>
\nSymbol: ANAB
\nPrice: $14.00-$16.00
\nDescription: They are a biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.
\nTrade Date: 1\/26
\nShares: 4 million
\nUnderwriter(s): Credit Suisse, Stifel
\nCo Manager(s): JMP Securities, Wedbush PacGrow<\/p>\n

Company: Jounce Therapeutics<\/strong>
\nSymbol: JNCE
\nPrice: $13.00-$15.00
\nDescription: They are a clinical stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients.
\nTrade Date: 1\/27
\nShares: 5.4 million
\nUnderwriter(s): J.P. Morgan, Cowen & Company
\nCo Manager(s): Wells Fargo Securities, Baird<\/p>\n

Company: Jagged Peak Energy<\/strong>
\nSymbol: JAG
\nPrice: $16.00-$18.00
\nDescription: They are a growth-oriented, independent oil and natural gas company focused on the acquisition and development of unconventional oil and associated liquids-rich natural gas reserves in the Southern Delaware Basin, a sub-basin of the Permian Basin of West Texas and one of the most prolific unconventional resource plays in North America.
\nTrade Date: 1\/27
\nShares: 38.2 million
\nUnderwriter(s): Citigroup, Credit Suisse, J.P. Morgan, Goldman Sachs & Co., RBC Capital Markets, Wells Fargo Securities
\nCo Manager(s): UBS Investment Bank, KeyBanc Capital Markets, ABN AMRO, Fifth Third Securities, Petrie Partners Securities, Tudor Pickering, Holt & Co., BMO Capital Markets, Deutsche Bank Securities, Evercore ISI, Scotia Howard Weil<\/p>\n

Company: JELD-WEN Holding<\/strong>
\nSymbol: JELD
\nPrice: $21.00-$23.00
\nDescription: They are one of the world\u2019s largest door and window manufacturers, and they hold the #1 position by net revenues in the majority of the countries and markets they serve.
\nTrade Date: 1\/27
\nShares: 25 million
\nUnderwriter(s): Barclays, Citigroup, Credit Suisse, J.P. Morgan, Deutsche Bank Securities, RBC Capital Markets, BofA Merrill Lynch, Goldman Sachs & Co., Wells Fargo Securities
\nCo Manager(s): Baird, FBR, SunTrust Robinson Humphrey<\/p>\n

Company: Visterra, Inc.<\/strong>
\nSymbol: VIST
\nPrice: $12.00-$14.00
\nDescription: They are a clinical-stage biopharmaceutical company focused on applying their novel Hierotope platform to identify unique disease targets and to design and engineer innovative antibody-based therapies that are intended to be effective as a single-dose administration.
\nTrade Date: 1\/27
\nShares: 3.9 million
\nUnderwriter(s): Leerink Partners, Stifel
\nCo Manager(s): Needham & Company, Wedbush PacGrow<\/p>\n

Company: REV Group<\/strong>
\nSymbol: REV
\nPrice: $19.00-$21.00
\nDescription: REV is a leading designer, manufacturer and distributor of specialty vehicles and related aftermarket parts and services.
\nTrade Date: 1\/27
\nShares: 12.5 million
\nUnderwriter(s): Goldman Sachs & Co., Morgan Stanley, Baird
\nCo Manager(s): BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, Jefferies, Wells Fargo Securities, Stifel<\/p>\n

Company: Laureate Education<\/strong>
\nSymbol: LAUR
\nPrice: $17.00-$21.00
\nDescription: Laureate is an international community of universities that encourages learning without boundaries.
\nTrade Date: 2\/1
\nShares: 29 million
\nUnderwriter(s): Credit Suisse, Morgan Stanley, Barclays, Macquarie Capital, J.P. Morgan, BMO Capital Markets, Citigroup, Goldman Sachs & Co
\nCo Manager(s): Baird, Barrington Research, Piper Jaffray, Stifel, William Blair, Bradesco BBI, BTG Pactual<\/p>\n

Company: Braeburn Pharmaceuticals<\/strong>
\nSymbol: BBRX
\nPrice: $18.00-$21.00
\nDescription: They are a commercial-stage pharmaceutical company focused on the development and commercialization of novel long-acting medications for serious disorders of the central nervous system, or CNS.
\nTrade Date: 2\/2
\nShares: 7.7 million
\nUnderwriter(s): J.P. Morgan, BofA Merrill Lynch, Deutsche Bank Securities
\nCo Manager(s): Canaccord Genuity<\/p>\n

Company: Sachem Capital<\/strong>
\nSymbol: SACH
\nPrice: $5.00-$5.00
\nDescription: They are a Connecticut-based real estate finance company that specializes in originating, underwriting, funding, servicing and managing a portfolio of short-term (i.e., three years or less) loans secured by first mortgage liens on real property located primarily in Connecticut.
\nTrade Date: TBD
\nShares: 3 million
\nUnderwriter(s): Joseph Gunnar & Co.
\nCo Manager(s): N\/A<\/p>\n","protected":false},"excerpt":{"rendered":"

SUBSCRIBE TO IPOBoutique\u2019s Free Weekly Newsletter   Link to entire IPO Boutique Pipeline NEW FILINGS Company: Foundation Building Materials Symbol: FBM Price: TBD Description: They are the second largest specialty distributor of wallboard and suspended ceiling systems in the United States and Canada, and the fastest growing by revenue and branch count since our founding[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[1019,987,1031,992,1016,986,1033,1018,1032,1034,1017],"class_list":["post-1679","post","type-post","status-publish","format-standard","hentry","category-ipo","tag-anab","tag-bbrx","tag-fbm","tag-jag","tag-jeld","tag-jnce","tag-laur","tag-obsv","tag-revg","tag-sach","tag-vist"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1679","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1679"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1679\/revisions"}],"predecessor-version":[{"id":1680,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1679\/revisions\/1680"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1679"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1679"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1679"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}